Phase 1 results of safety and tolerability in a rush oral immunotherapy protocol to multiple foods using Omalizumab
収録刊行物
-
- Allergy, Asthma & Clinical Immunology
-
Allergy, Asthma & Clinical Immunology 10 (1), 7-, 2014-02-27
Springer Science and Business Media LLC